Ckd Bio
CKD Bio Corp. engages in the manufacturing and sale of pharmaceutical products in South Korea, Europe, Asia, the Middle East, and internationally. The company is also involved in real estate leasing and related ancillary; bio, cosmetics, and health functional food; property management; advertising communication; consulting, construction, and maintenance of corporate IT systems business. It also e… Read more
Ckd Bio (063160) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.011x
Based on the latest financial reports, Ckd Bio (063160) has a cash flow conversion efficiency ratio of -0.011x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.47 Billion) by net assets (₩128.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Ckd Bio - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Ckd Bio's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Ckd Bio Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ckd Bio ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Confidence Petroleum India Limited
NSE:CONFIPET
|
0.057x |
|
Calidus Resources Ltd
PINK:CALRF
|
0.056x |
|
Amarc Resources Ltd
OTCQB:AXREF
|
-169.785x |
|
Millennium Grp Corp (Asia)
BK:MGC
|
0.174x |
|
Sachem Capital Corp
NYSE MKT:SACH
|
0.028x |
|
Ramada Investimentos e Industria S.A
LS:RAM
|
0.094x |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
0.047x |
|
GiG Software PLC
ST:GIG-SDB
|
0.010x |
Annual Cash Flow Conversion Efficiency for Ckd Bio (2008–2024)
The table below shows the annual cash flow conversion efficiency of Ckd Bio from 2008 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩131.01 Billion | ₩14.03 Billion | 0.107x | +282.39% |
| 2023-12-31 | ₩123.02 Billion | ₩-7.22 Billion | -0.059x | -170.82% |
| 2022-12-31 | ₩147.80 Billion | ₩-3.20 Billion | -0.022x | +40.47% |
| 2021-12-31 | ₩161.49 Billion | ₩-5.88 Billion | -0.036x | -227.41% |
| 2020-12-31 | ₩168.75 Billion | ₩4.82 Billion | 0.029x | -73.34% |
| 2019-12-31 | ₩158.46 Billion | ₩16.99 Billion | 0.107x | +1.91% |
| 2018-12-31 | ₩147.66 Billion | ₩15.54 Billion | 0.105x | -26.90% |
| 2017-12-31 | ₩142.05 Billion | ₩20.45 Billion | 0.144x | +25.52% |
| 2016-12-31 | ₩135.16 Billion | ₩15.50 Billion | 0.115x | +1.87% |
| 2015-12-31 | ₩127.38 Billion | ₩14.34 Billion | 0.113x | +22.22% |
| 2014-12-31 | ₩121.85 Billion | ₩11.22 Billion | 0.092x | +4.45% |
| 2013-12-31 | ₩123.87 Billion | ₩10.92 Billion | 0.088x | -52.19% |
| 2012-12-31 | ₩124.15 Billion | ₩22.90 Billion | 0.184x | +69.33% |
| 2011-12-31 | ₩119.00 Billion | ₩12.96 Billion | 0.109x | -65.28% |
| 2010-12-31 | ₩76.14 Billion | ₩23.89 Billion | 0.314x | -24.35% |
| 2009-12-31 | ₩64.08 Billion | ₩26.57 Billion | 0.415x | +90.70% |
| 2008-12-31 | ₩49.15 Billion | ₩10.69 Billion | 0.217x | -- |